DOI: https://doi.org/10.22141/2224-1507.3.11.2013.82331

Effect of Bisphosphonates on Fracture Union

N.V. Dedukh, V.V. Povoroznyuk

Abstract


.

References


Goldhahn I., Little D., Mitchell P. et al. Evidence for anti-osteoporosis therapy in acute fracture situations — Recommendations of a multidisciplinary workshop of the International Society for Fracture Repaire // Bone. — 2010. — 46(2). — P. 267-271.

Fleisch H. Bisphosphonates: Mechanics of action // Endocr. Rev. — 1998. — 19. — P. 80-100.

Lin J., Lane J. Bisphosphonates // Journal of the American Academy of Orthopaedic Surgeons. — 2003. — 11. — P. 1-4.

Lane J., Khan S., O’Connor W. et al. Bisphosphonate therapy in fibrous dysplasia // Clinical Orthopaedics and Related Research. — 2001. — 382. — P. 6-2.

Hodsman B., Hanley D.A., Josse R. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis // J. Bone Miner. Res. — 2004. — 19(8). — P. 1241-1249.

Lyles K.W., Colón-Emeric C.S., Magaziner J.S. et al., for the HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture // N. Engl. J. Med. — 2007. — 357. — P. 1799-1809.

Black D.M. et al. The Effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: a randomized extension to the ­HORIZON-pivotal fracture trial (PFT) // American Society for Bone and Mineral Research (ASBMR) Annual Meeting. — October 16, 2010. — Электронный ресурс [точка доступа]: www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=4781a020-dc3a-46be-b49d-f706b5509c4e

Li J., Mori S., Kaji Y. et al. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats // J. Bone Miner. Res. — 1999. — 14. — P. 969-979.

Fleisch H. Can bisphosphonates be given to patients with fractures? // Bone Miner. Res. — 2001. — 16. — P. 437-440.

Li C., Mori S., Li J. et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats // Journal of Bone and Mineral Research. — 2001. — 16. — P. 429-436.

Nyman M.T., Gao T., Lindholm T.C., Lindholm T.S. Healing of a tibial double osteotomy is modified by clodronate administration // Arch. Orthop. Trauma Surg. — 1996. — 115. — P. 111-116.

Nyman M.T., Paavolainen P., Lauren L., Arnala I. Short term clodronate treatment does not increase trabecular bone in post-traumatic osteopenia // Ann. Chir. Gynaecol. — 1995. — 84. — P. 296-301.

Nyman M.T., Paavolainen P., Lindholm T.S. Clodronate increases the calcium content in fracture callus: an experimental study in rats // Arch. Orthop. Trauma Surg. — 1993. — 112. — P. 228-231.

Tarvainen R., Olkkonen H., Nevalainen T. et al. Effect of clodronate on fracture healing in denervated rats // Bone. — 1994. — Vol. 15. — P. 701-705.

Abass B.T., Shekho H.A.T. Effects of tiludronate on healing of femoral fracture in dogs // Iraqi Journal of Veterinary Sciences. — 2009. — 23(II). — P. 129-134.

Kidd L.J., Cowling N.R., Wu A.C. et al. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna // J. Orthop. Res. — 2011. — 29(12). — P. 1827-1833.

De Olivera L.A.A., Guarniero R., Rodriges C.J. et al. The evaluation of the sodic risedronate effect in the fractures consolidation experimental study with rats // Acta Orthop. Bras. — 2004. — 12(2). — P. 77-83.

Peter C., Cook W., Nunamaker D. et al.Effect of alendronate on fracture healing and bone remodeling in dogs // Journal of Orthopaedic Research. — 1996. — 14. — P. 74-79.

Cao Y., Mori S., Mashiba T. et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats // Journal of Bone and Mineral Research. — 2002. — 17. — P. 2237-2246.

Goodship A.E., Walker P.C., McNally D. et al. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone // Ann. Oncol. — 1994. — 5(7). — S53-55.

Little D.G., Cornell M.S., Hile M.S. et al. Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosis // Injury. — 2001. — 32(4). — SD14-SD20.

Little D.G., Cornell M.S., Briody J. et al. Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits // J. Bone & Joint Surg. — 2001. — 83B. — P. 1069-1074.

Amanat N., Brown R., Bilston L., Little D. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair // Journal of Orthopaedic Research. — 2005. — 23. — P. 1029-1034.

Matos M.A., Araújo F.P., Paixão F.B. The effect of zoledronate on bone remodeling during the healing process // Acta Cirúrgica Brasileira. — 22(2). — 2007. — Р. 115-119.

Amanat N., McDonald M., Godfrey C. et al. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair // J. Bone Miner. Res. — 2007. — 22(6). — P. 867-876.

McDonald M.M., Dulai S.K., Godfrey C. et al. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling // Bone. — 2008. — 43(4). — P. 653-662.

Поворознюк В.В., Вайда В.М., Дєдух Н.В., Григор’єва Н.В. Вплив препарату «Акласта» на структурно-функціональний стан кісткової тканини та процеси репаративного остеогенезу в умовах постменопаузального остеопорозу // Ортопедия, травматология и протезирование. — 2011. — 2. — С. 26-32.

Matos M.A. The effect of zoledronate during bone healing // J. Orthopaed. Traumatol. — 2010. — 11. — P. 7-12.

Yu Y.Y., Lieu S., Hu D. et al. Site specific effects of zoledronic acid during tibial and mandibular fracture repair // PLoS ONE. — 2012. — 7(2). — P. e31771.

Manabe T., Mori S., Mashiba T. et al. Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model // Calcif. Tissue Int. — 2012. — 90. — P. 193-201.

Guarniero R., Vaz C.E.S., Santana P.J.D. et al. Evaluation of ibandronate effects in bone healing: experimental study in rabbits // Rev. Bras. Ortop. [online]. — 2007. — 42(8). — P. 254-260.

Bauss F., Schenk R.K., Hört S. et al. New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate // J. Pharmacol. Toxicol. Methods. — 2004. — 50(1). — P. 25-34.

Hoang-Kim A., Gelsomini L., Luciani D. et al. Fracture healing and drug therapies in osteoporosis // Clinical Cases in Mineral and Bone Metabolism. — 2009. — 6(2). — P. 136-143.

Mashiba T. Morphological analysis of bone dynamics and metabolic bone disease. Histological findings in animal fracture mo­del — effects of osteoporosis treatment drugs on fracture healing process // Clin. Calcium. — 2011. — 21(4). — P. 551-558.

Adolphson P., Abbaszadegan H., Boden H. et al. Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients // Acta Orthopaedica Scandinavia. — 2000. — 71. — P. 195-200.

Van der Poest Clement E., van Engeland M., Ader H. et al. Alendronate in the prevention of bone loss after a fracture of the lower leg // Journal of Bone and Mineral Research. — 2002. — 17. — P. 2247-2255.

Van der Poest Clement E., Patka P., Vandormael K. et al. The effect of alendronate on bone mass after distal forearm fracture // Journal of Bone and Mineral Research. — 2000. — 15. — P. 586-593.

Colón-Emeric C., Nordsletten L., Olson S. et al. HORIZON Recurrent Fracture Trial Association between timing of zoledronic acid infusion and hip fracture healing // Osteoporos. Int. — 2011. — 22(8). — P. 2329-2336.

Eriksen E.F., Lyles K.W., Colón-Emeric C.S. et al. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture // J. Bone Miner. Res. — 2009. — 24. — P. 1308-1313.

Shina Y., Engebretsen L., Iwasa J. et al. Use of bisphosphonates for the treatment of stress fractures in athletes // Knee Surg. Sports Traumatol. Arthrosc. — 2011. — 17(5). — P. 542-550.

Kim T.Y., Ha Y.C., Kang B.J. et al. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? // J. Bone and J. Surg. — 2012. — 94. — P. 542-550.






Copyright (c) 2020 N.V. Dedukh, V.V. Povoroznyuk

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2020

 

   Seo анализ сайта